TA Associates Revives Sale of $1bn Cosmetics Firm Vivacy

TA Associates Revives Sale of $1bn Cosmetics Firm Vivacy

TA Associates is reviving plans to sell French cosmetic treatment company Laboratoires Vivacy, people familiar with the matter said. The buyout firm is working with BNP Paribas SA and Rothschild & Co. on a potential divestment that could value Vivacy at about 1...
abrdn confirms plans to merge or close 100 funds

abrdn confirms plans to merge or close 100 funds

abrdn is merging or shuttering 100 funds in a move to save on costs, the Scottish investment house confirmed to Investment Week, as AUM at its asset management arm declined 17% in the first half of 2022. A spokesperson said: “We have now reviewed around 550...
Blue Owl’s Dyal in Talks to Buy Stake in PAI Partners

Blue Owl’s Dyal in Talks to Buy Stake in PAI Partners

Blue Owl Capital’s Dyal Capital arm is in talks to acquire a stake in private equity firm PAI Partners, according to people familiar with the matter. Dyal is in preliminary discussions about the potential purchase of a minority holding in PAI, the people said, asking...
Inflexion exits Pharmaspectra in $100m deal

Inflexion exits Pharmaspectra in $100m deal

Inflexion has exited its investment in Pharmaspectra, a leading global provider of medical affairs data and analytics to the pharmaceutical and biotech industry, to a listed trade buyer. This sale follows strong continued exit momentum for Inflexion with nine exits...